Noble Capital Markets

Noble Capital Markets

Thomas J. Healy founded Noble Capital Markets in 1984, building it as a boutique broker-dealer that would eventually carve out an unusual niche: company-sponsored equity research. The firm's headquarters sit in Boca Raton, with additional offices in St. Louis and New York. Noble is not a family office but an employee-owned investment bank and broker-dealer regulated by FINRA. Its revenue model flips the traditional sell-side paradigm — instead of subsidizing research with trading commissions or investment banking fees from large-cap names, Noble charges issuers directly for initiation and ongoing coverage. Noble focuses almost exclusively on small- and micro-cap public companies, a universe largely abandoned by bulge-bracket banks after MiFID II and the unbundling of research costs. The firm provides equity research, institutional sales and trading, and investment banking services — covering capital raises, M&A advisory, and fairness opinions. Noble's equity research spans sectors including healthcare services, enterprise software, energy transition, and industrial technology. Its investment banking team has executed public offerings and private placements for companies like Crexendo, a cloud communications platform, and several clinical-stage biotech firms. The firm actively markets its conference platform, hosting multiple sector-specific investor events each year, which serve as a deal-sourcing and distribution funnel for both banking and research. Noble employs FINRA-registered representatives across its three offices. In recent years, the firm has emphasized its democratized-access pitch — offering retail and institutional investors direct access to management teams through digital channels. In May 2024, Noble expanded its company-sponsored research platform by adding coverage of a precision oncology diagnostics firm (per the firm's official communications, May 2024). The firm maintains a charitable arm, the Noble Circle of Giving, which directs a portion of conference proceeds and firm donations to local South Florida causes. Noble's structural differentiator is permanent. It operates where the traditional sell-side has structurally retreated. By charging issuers for research — a practice widely considered conflicted under the old commission-based regime — Noble transparently acknowledges the economic alignment and exists entirely to serve companies too small to attract conventional analyst attention. This is not a hybrid model; it is a full inversion of the broker-dealer incentive structure, made viable by the post-MiFID erosion of bank-sponsored small-cap desks.